hotspot -WSS

hotspot

author：hotspot 2025-08-23 08:57:01 - browse：5

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： House transparency, PBM reform bill gains bipartisan support

Wikipedia

WSS

How to protect patients from sexual assault

How to protect patients from sexual assault

How to protect patients from sexual assault

Publishing genetic code of viruses could cause disaster

Listen: Biogen's potential pivot, & Illumina's next chapter

First transplant of an entire human eye performed

hotspot

hotspot

focus

Activists slam private health insurers over coverage restrictions

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

ChatGPT in medicine: STAT answers readers' burning questions

Trump surgeon general acknowledges mistakes during Covid

Anesthesiologist group: stop taking Ozempic before surgery

Ohio still needs to do more to protect the right to abortion

Sports medicine is finally prioritizing gender equality

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Virginia high school admissions case could be legal follow

Humana sues Biden admin over Medicare Advantage audit rule

focus

CVS, Rite Aid closures threaten to worsen pharmacy deserts

White House drug czar issues call for 'recovery

Crinetics acromegaly drug succeeds in late

Experimental asthma app from Apple and Anthem shows promise

Why Novartis is changing the name of its research labs

After decades in use, heart stents finally beat placebo

explore

knowledge

Wikipedia

hotspot